Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Blier

Showing results (21-30 of 229) with videos related to

Pageof 23
Sort By:
The American Journal of Psychiatry|January 7, 2012
Combined treatments for depression as for other medical disordersPierre Blier
Journal of Psychopharmacology (Oxford, England)|August 1, 2007
Generic medications: another variable in the treatment of illnessesPierre Blier
Journal of Psychiatry & Neuroscience : JPN|January 7, 2009
Optimal use of antidepressants: when to act?Pierre Blier
Journal of Affective Disorders|January 12, 2011
Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorderPierre Blier, Claude Blondeau
CNS Spectrums|June 29, 2004
Toward optimal treatments for major depressionPierre Blier, Herbert Ward
Journal of Psychopharmacology (Oxford, England)|July 7, 2012
A framework to avoid irrational polypharmacy in psychiatryDaniel Zigman, Pierre Blier
The Journal of Clinical Psychiatry|May 11, 2006
Physiologic mechanisms underlying the antidepressant discontinuation syndromePierre Blier, Philippe Tremblay
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 23, 2013
Monoamine neurocircuitry in depression and strategies for new treatmentsMichel Hamon, Pierre Blier
L'Encephale|April 23, 2023
Remission from severe treatment-resistant depression with moclobemide: A case reportSimon Lafrenière, Pierre Blier
The International Journal of Neuropsychopharmacology|August 5, 2016
A Neuroscience-Based Nomenclature (NbN) for Psychotropic AgentsAlan Frazer, Pierre Blier
Pageof 23

Showing results (21-30 of 229) with videos related to

Sort By:
Pageof 23
The American Journal of Psychiatry|January 7, 2012
Combined treatments for depression as for other medical disordersPierre Blier
Journal of Psychopharmacology (Oxford, England)|August 1, 2007
Generic medications: another variable in the treatment of illnessesPierre Blier
Journal of Psychiatry & Neuroscience : JPN|January 7, 2009
Optimal use of antidepressants: when to act?Pierre Blier
Journal of Affective Disorders|January 12, 2011
Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorderPierre Blier, Claude Blondeau
CNS Spectrums|June 29, 2004
Toward optimal treatments for major depressionPierre Blier, Herbert Ward
Journal of Psychopharmacology (Oxford, England)|July 7, 2012
A framework to avoid irrational polypharmacy in psychiatryDaniel Zigman, Pierre Blier
The Journal of Clinical Psychiatry|May 11, 2006
Physiologic mechanisms underlying the antidepressant discontinuation syndromePierre Blier, Philippe Tremblay
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 23, 2013
Monoamine neurocircuitry in depression and strategies for new treatmentsMichel Hamon, Pierre Blier
L'Encephale|April 23, 2023
Remission from severe treatment-resistant depression with moclobemide: A case reportSimon Lafrenière, Pierre Blier
The International Journal of Neuropsychopharmacology|August 5, 2016
A Neuroscience-Based Nomenclature (NbN) for Psychotropic AgentsAlan Frazer, Pierre Blier
Pageof 23